Regulus Therapeutics Inc. financial data

Symbol
RGLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
4224 Campus Point Court, Suite 210, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 672 % +37.9%
Debt-to-equity 18.5 % -45.7%
Return On Equity -65.7 % +18.9%
Return On Assets -55.5 % +8.29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 65.5 M shares +289%
Common Stock, Shares, Outstanding 65.5 M shares +288%
Entity Public Float 27.4 M USD -5.52%
Common Stock, Value, Issued 65 K USD +282%
Weighted Average Number of Shares Outstanding, Basic 28.7 M shares +70.7%
Weighted Average Number of Shares Outstanding, Diluted 28.7 M shares +70.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 22.3 M USD +13.3%
General and Administrative Expense 10.3 M USD +9.76%
Operating Income (Loss) -32.6 M USD -12.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.4 M USD -9.13%
Income Tax Expense (Benefit) 1 K USD 0%
Net Income (Loss) Attributable to Parent -31.4 M USD -9.13%
Earnings Per Share, Basic 1.71 USD/shares -10%
Earnings Per Share, Diluted 1.71 USD/shares -10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.6 M USD -2.38%
Cash, Cash Equivalents, and Short-term Investments 108 M USD +255%
Other Assets, Current 821 K USD -30.3%
Assets, Current 101 M USD +194%
Property, Plant and Equipment, Net 1.09 M USD +120%
Operating Lease, Right-of-Use Asset 1.33 M USD -30.1%
Intangible Assets, Net (Excluding Goodwill) 30 K USD -48.3%
Other Assets, Noncurrent 74 K USD
Assets 114 M USD +208%
Accounts Payable, Current 406 K USD -30.1%
Employee-related Liabilities, Current 1.19 M USD +15.9%
Accrued Liabilities, Current 604 K USD -9.99%
Liabilities, Current 5.68 M USD -35.6%
Operating Lease, Liability, Noncurrent 868 K USD -45.7%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 6.55 M USD -37.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -45 K USD
Retained Earnings (Accumulated Deficit) -522 M USD -6.4%
Stockholders' Equity Attributable to Parent 108 M USD +305%
Liabilities and Equity 114 M USD +208%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.74 M USD -7.74%
Net Cash Provided by (Used in) Financing Activities 93.1 M USD
Net Cash Provided by (Used in) Investing Activities -78.5 M USD -624%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 65.5 M shares +288%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.82 M USD -4.29%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.6 M USD -2.38%
Interest Paid, Excluding Capitalized Interest, Operating Activities 45 K USD -69.6%
Deferred Tax Assets, Valuation Allowance 140 M USD +6.11%
Deferred Tax Assets, Gross 141 M USD +5.96%
Operating Lease, Liability 1.6 M USD -29.4%
Payments to Acquire Property, Plant, and Equipment 229 K USD +22800%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -31.4 M USD -9.33%
Lessee, Operating Lease, Liability, to be Paid 1.71 M USD -31.4%
Property, Plant and Equipment, Gross 5.31 M USD +7.08%
Operating Lease, Liability, Current 730 K USD +9.94%
Lessee, Operating Lease, Liability, to be Paid, Year Two 277 K USD -66.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 824 K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107 K USD -52.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 277 K USD -66.4%
Deferred Tax Assets, Operating Loss Carryforwards 92.6 M USD +2.8%
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 1 K USD 0%
Unrecognized Tax Benefits 6.25 M USD +8.04%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 776 K USD +2.92%
Current State and Local Tax Expense (Benefit) 1 K USD 0%
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 100 K USD 0%
Depreciation, Depletion and Amortization 81 K USD +68.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 3.38 M USD +113%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 500 K USD -30.4%